AI and clinical trial access may hold the key to reducing oncology denials, as experts from PayerWatch and Massive Bio ...

Cellular therapies that harness a patient’s own immune system to identify and eliminate cancer cells are rapidly expanding ...

Fox Chase researchers use 3D genomic testing to improve lymphoma and sarcoma diagnosis and treatment by revealing tumor cell ...

ThedaCare Regional Cancer Center marks 10 years of care, innovation, and expanded access to cancer services across northeast ...

Nonprofit founded by Stage IV lung cancer patient supports precision oncology research aimed at expanding treatment options for advanced cancersATLANTA, March 31, 2026 (GLOBE NEWSWIRE) -- Stage4Hope™, ...

At Phoebe Putney Health System’s Cancer Center, a boutique is helping patients navigate those changes with confidence.

OhioHealth has started construction on a five‑story cancer center in Columbus, consolidating outpatient oncology services by ...

The National Comprehensive Cancer Network® (NCCN®)-a non-profit alliance of leading cancer centers-brought together more than a thousand oncology professionals at the NCCN 2026 Annual Conference in ...

Take these 7 steps after receiving a cancer diagnosis to process your emotions, line up support, and prepare to start ...

The phase 3 ATOMIC trial is changing the way we treat stage III dMMR colon cancer. In this video, Dr. Sinicrope breaks down the landmark findings, and explains why this trial is now considered ...

The University of Mississippi Medical Center's "It's About Time" campaign has raised over $100 million for a new cancer center.

Alphamab Oncology (stock code: 9966.HK) today announced that HER2 bispecific antibody Anbenitamab Injection (KN026), independently developed by the Company, and co-developed with JMT-Bio Technology Co ...